Zobrazeno 1 - 10
of 10
pro vyhledávání: '"V. G. Pustozerov"'
Autor:
T. A. Bairova, A. Yu. Sambyalova, L. V. Rychkova, E. A. Novikova, F. I. Belyalov, D. S. Sargaeva, E. A. Shchedreeva, T. G. Ignatyeva, O. A. Ershova, V. G. Pustozerov, O. A. Kovaleva, I. V. Rasputina, I. A. Noskova, T. V. Batogova, O. V. Kuznetsova, O. Yu. Bogoslova, S. I. Kolesnikov
Publikováno v:
Acta Biomedica Scientifica, Vol 4, Iss 3, Pp 40-44 (2019)
Background. To date, there are many pharmacogenetic algorithms for selecting the dose of warfarin. However, there is very little information about the predictive accuracy of the algorithms. We decided to evaluate the predictive accuracy of the Gage a
Externí odkaz:
https://doaj.org/article/fdd59ed4b8944642a700c707dfda6c18
Autor:
T. A. Bairova, E. A. Novikova, F. I. Belyalov, E. A. Shchedreeva, K. D. Ievleva, O. V. Kalyuzhnaya, O. A. Ershova, V. G. Pustozerov, O. A. Kovaleva, I. V. Rasputina, I. A. Noskova, T. V. Batogova, O. V. Kuznetsova, O. Yu. Bogoslova, S. I. Kolesnikov
Publikováno v:
Acta Biomedica Scientifica, Vol 3, Iss 5, Pp 39-48 (2018)
Background. Genotypes of the cytochrome p450 isoform (CYP2C9 and CYP4F2) determine warfarin dose requirements. Frequencies of risk alleles and genotypes of CYP2C9 and CYP4F2 gene vary in different races and ethnic groups.Aim. This study analyzed the
Externí odkaz:
https://doaj.org/article/8e762c6af4b64e6db4852c2a89e3a334
Autor:
V. G. Pustozerov, Y. V. Bazhenova
Publikováno v:
Acta Biomedica Scientifica, Vol 0, Iss 5(1), Pp 79-83 (2012)
The information about epidemiology of osteoporotic injuries of vertebras among people of elderly and senile age of Irkutsk is provided in the article. It is shown that frequency of these injuries is 28 % (33,9 % in women and. 22,2 % in men), and. ost
Externí odkaz:
https://doaj.org/article/24338cde0aa4469da657b7bcd5c273c1
Publikováno v:
Neurology Bulletin. :51-54
The experience of recovery and rehabilitation of patients with hereditary neuromuscular diseases (more than 1000 observations) is generalized. Their own methods of pathogenetic and correcting therapy as well as patented methods are described. Their t
Autor:
V. D. Kosachev, Т. M. Alekseeva, Т. N. Vasilyeva, I. G. Zavolokov, L. A. Saikova, V. G. Pustozerov
Publikováno v:
Neurology Bulletin. :81-83
For determination criteria of differential diagnosis analysis of clinical manifestations and indices of additional research methods (EMG, ENMY, biochemical, histomorphological) of paroxysmal hypokinetic conditions in myoplegia, myopathic syndromes, g
Publikováno v:
Likars'ka sprava. (4)
Bemithyl treatment was carried out in 22 patients with neuromuscular diseases (progressive myodystrophy). The actoprotector bemithyl inhibited in these patients the processes of lipid peroxidation, activation of neoglucogenesis favours improvement of
Publikováno v:
Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952). 91(9)
Studies into the mechanism of the therapeutic action of bemitil were carried out in 21 patients with neuromuscular diseases. Measurements of lipid peroxidation and permeability of the erythrocytic membranes demonstrated the drug to influence carbohyd
Publikováno v:
Sovetskaia meditsina. (9)
Publikováno v:
Klinicheskaia khirurgiia. (10)
Publikováno v:
Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952). 90(3)
To improve the peripheral circulation, to exert an antihypoxic action on muscle tissue, to stimulate oxidation processes, to relieve the physiological phase of myorelaxation, and to diminish the intensity of myotonic reactions, 34 patients with myoto